Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
5m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
32m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Hoth Therapeutics Inc logo

Hoth Therapeutics Inc

About

Hoth Therapeutics Inc (NASDAQ:HOTH) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 14 2026
Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide
Apr 2 2026
Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering
Apr 1 2026
Hoth Therapeutics Announces $2.0 Million Registered Direct Offering
Mar 31 2026
Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology
Mar 26 2026
Hoth Therapeutics Deploys OpenClaw™ AI Platform to Accelerate Drug Discovery

Financials

Revenue
$0
Market Cap
$9.41 M
EPS
-0.90

Community Chat

Ask AI

6ix6ixAIEvents